Plus   Neg

Realty Income Prices Public Offering Of 10.5 Mln Shares At $57.05/Shr - Quick Facts

Realty Income Corp (O) announced that it has priced public offering of 10.5 million shares of $57.05 per share and is expected to close January 14, 2021.

The company granted underwriters a 30-day option to purchase up to 1,575,000 additional shares of common stock.

The company expects offering net proceeds, after underwriting discounts and commissions, but before expenses, will be about $582.3 million.

The joint book-running managers for the offering are BofA Securities, Morgan Stanley, Wells Fargo Securities and Citigroup.

The company intends to use offering net proceeds, along with available cash and additional borrowings as necessary, to fund property acquisitions and the remaining net proceeds will be used for general corporate purposes and working capital.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test. AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory...
Follow RTT